Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia
Aims To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia. Design Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enha...
Gespeichert in:
Veröffentlicht in: | Addiction (Abingdon, England) England), 2013-08, Vol.108 (8), p.1387-1396 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1396 |
---|---|
container_issue | 8 |
container_start_page | 1387 |
container_title | Addiction (Abingdon, England) |
container_volume | 108 |
creator | Shin, Sonya Livchits, Viktoria Connery, Hilary Smith Shields, Alan Yanov, Sergei Yanova, Galina Fitzmaurice, Garrett M. Nelson, Adrianne K. Greenfield, Shelly F. |
description | Aims
To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia.
Design
Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enhancement therapy (BBCET), treatment as usual (TAU) and BCI.
Setting and participants
In the Tomsk Oblast, hospitalized TB patients diagnosed with alcohol use disorders (AUDs) by the DSM‐IV were referred at the start of TB treatment. Of the 196 participants, the mean age was 41 years and 82% were male. Severe TB (84.7% had cavitary disease) and smoking (92.9%) were common. The majority had a diagnosis of an AUD (63.0%); 27.6% reported nearly daily drinking and consumed a median of 16 standard drinks per day.
Measurements
Primary outcomes were ‘favorable’ TB outcome (cured, completed treatment) and change in mean number of abstinent days in the last month of study compared with baseline. Change in mean number of heavy drinking days, defined as four drinks per day and five drinks per day for women and men, respectively, and TB adherence, measured as percentage of doses taken as prescribed under direct observation, were secondary outcomes. Analysis based on ‘intention‐to‐treat’ was performed for multivariable analysis.
Findings
Primary TB and alcohol end‐points between naltrexone and no‐naltrexone or BCI and no‐BCI groups did not differ significantly. TB treatment adherence and change in number of heavy drinking days also did not differ significantly among treatment arms. Among individuals with a prior quitting attempt (n = 111), naltrexone use was associated with an increased likelihood of favorable TB outcomes (92.3% versus 75.9%, P = 0.02).
Conclusions
In Tomsk Oblast, Russia, tuberculosis patients with severe alcohol use disorders who were not seeking alcohol treatment did not respond to naltrexone or behavioral counselling integrated into tuberculosis care; however, those patients with past attempts to quit drinking had improved tuberculosis outcomes. |
doi_str_mv | 10.1111/add.12148 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3710528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1430853998</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5468-e4208b8cb307cfeddaa0419b7df8b02fcbd9ffd6963cc83d3f062d8b9ef8896d3</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxSMEokvhwBdAkbhwIO04dhL7glS6_YOoQEVFHC3HHrfuJnGxnUK_Pe5uWQEnfPHY85unJ_sVxUsCeySvfWXMHqkJ44-KBaEtVMAYfVwsQLRNle9hp3gW4zUAdFywp8VOTZkACmxRrI6sRZ3cLU4YY-ltqQbtr_xQpoAqjTil0k0JQwaS81Ncny6DSmjuS18GPyc3YZnmHoOeBx9dLLUKmNvlhR_j6m35ZY7RqefFE6uGiC8e9t3i6_HRxeFpdfb55MPhwVmlG9byClkNvOe6p9Bpi8YoBYyIvjOW91Bb3RthrWlFS7Xm1FALbW14L9ByLlpDd4t3G92buR_R6Ow8qEHeBDeqcCe9cvLvzuSu5KW_lbQj0NQ8C7x5EAj--4wxydFFjcOgJvRzlIRR4A0V4n9Q0vGGQ91k9PU_6LWfw5RfQpKsRWsmWJ2pV3-a37r-_WUZ2N8AP9yAd9s-AXmfBZmzINdZkAfL5brIE9VmwsWEP7cTKqxk29Gukd8-ncjj0-X7jy2cy3P6C0bHuEc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1399324942</pqid></control><display><type>article</type><title>Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Shin, Sonya ; Livchits, Viktoria ; Connery, Hilary Smith ; Shields, Alan ; Yanov, Sergei ; Yanova, Galina ; Fitzmaurice, Garrett M. ; Nelson, Adrianne K. ; Greenfield, Shelly F.</creator><creatorcontrib>Shin, Sonya ; Livchits, Viktoria ; Connery, Hilary Smith ; Shields, Alan ; Yanov, Sergei ; Yanova, Galina ; Fitzmaurice, Garrett M. ; Nelson, Adrianne K. ; Greenfield, Shelly F. ; Tomsk Tuberculosis Alcohol Working Group</creatorcontrib><description>Aims
To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia.
Design
Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enhancement therapy (BBCET), treatment as usual (TAU) and BCI.
Setting and participants
In the Tomsk Oblast, hospitalized TB patients diagnosed with alcohol use disorders (AUDs) by the DSM‐IV were referred at the start of TB treatment. Of the 196 participants, the mean age was 41 years and 82% were male. Severe TB (84.7% had cavitary disease) and smoking (92.9%) were common. The majority had a diagnosis of an AUD (63.0%); 27.6% reported nearly daily drinking and consumed a median of 16 standard drinks per day.
Measurements
Primary outcomes were ‘favorable’ TB outcome (cured, completed treatment) and change in mean number of abstinent days in the last month of study compared with baseline. Change in mean number of heavy drinking days, defined as four drinks per day and five drinks per day for women and men, respectively, and TB adherence, measured as percentage of doses taken as prescribed under direct observation, were secondary outcomes. Analysis based on ‘intention‐to‐treat’ was performed for multivariable analysis.
Findings
Primary TB and alcohol end‐points between naltrexone and no‐naltrexone or BCI and no‐BCI groups did not differ significantly. TB treatment adherence and change in number of heavy drinking days also did not differ significantly among treatment arms. Among individuals with a prior quitting attempt (n = 111), naltrexone use was associated with an increased likelihood of favorable TB outcomes (92.3% versus 75.9%, P = 0.02).
Conclusions
In Tomsk Oblast, Russia, tuberculosis patients with severe alcohol use disorders who were not seeking alcohol treatment did not respond to naltrexone or behavioral counselling integrated into tuberculosis care; however, those patients with past attempts to quit drinking had improved tuberculosis outcomes.</description><identifier>ISSN: 0965-2140</identifier><identifier>EISSN: 1360-0443</identifier><identifier>DOI: 10.1111/add.12148</identifier><identifier>PMID: 23490304</identifier><identifier>CODEN: ADICE5</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Addiction ; Adult ; Alcohol Abstinence ; Alcohol Deterrents - therapeutic use ; Alcohol interventions ; alcohol use disorders ; Alcoholism ; Alcoholism - complications ; Alcoholism - prevention & control ; Behavior Therapy - methods ; behavioral interventions ; Clinical outcomes ; clinical trial ; Combined Modality Therapy ; Compliance ; Counseling ; Feasibility Studies ; Female ; Humans ; Intervention ; Male ; Medical treatment ; Mycobacterium ; Naltrexone - therapeutic use ; Patient Compliance ; Patients ; Russia ; Russian Federation ; Treatment Outcome ; Tuberculosis ; Tuberculosis - complications ; Tuberculosis - therapy</subject><ispartof>Addiction (Abingdon, England), 2013-08, Vol.108 (8), p.1387-1396</ispartof><rights>2013 The Authors, Addiction © 2013 Society for the Study of Addiction</rights><rights>2013 The Authors, Addiction © 2013 Society for the Study of Addiction.</rights><rights>2013 Society for the Study of Addiction</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5468-e4208b8cb307cfeddaa0419b7df8b02fcbd9ffd6963cc83d3f062d8b9ef8896d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fadd.12148$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fadd.12148$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23490304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shin, Sonya</creatorcontrib><creatorcontrib>Livchits, Viktoria</creatorcontrib><creatorcontrib>Connery, Hilary Smith</creatorcontrib><creatorcontrib>Shields, Alan</creatorcontrib><creatorcontrib>Yanov, Sergei</creatorcontrib><creatorcontrib>Yanova, Galina</creatorcontrib><creatorcontrib>Fitzmaurice, Garrett M.</creatorcontrib><creatorcontrib>Nelson, Adrianne K.</creatorcontrib><creatorcontrib>Greenfield, Shelly F.</creatorcontrib><creatorcontrib>Tomsk Tuberculosis Alcohol Working Group</creatorcontrib><title>Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia</title><title>Addiction (Abingdon, England)</title><addtitle>Addiction</addtitle><description>Aims
To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia.
Design
Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enhancement therapy (BBCET), treatment as usual (TAU) and BCI.
Setting and participants
In the Tomsk Oblast, hospitalized TB patients diagnosed with alcohol use disorders (AUDs) by the DSM‐IV were referred at the start of TB treatment. Of the 196 participants, the mean age was 41 years and 82% were male. Severe TB (84.7% had cavitary disease) and smoking (92.9%) were common. The majority had a diagnosis of an AUD (63.0%); 27.6% reported nearly daily drinking and consumed a median of 16 standard drinks per day.
Measurements
Primary outcomes were ‘favorable’ TB outcome (cured, completed treatment) and change in mean number of abstinent days in the last month of study compared with baseline. Change in mean number of heavy drinking days, defined as four drinks per day and five drinks per day for women and men, respectively, and TB adherence, measured as percentage of doses taken as prescribed under direct observation, were secondary outcomes. Analysis based on ‘intention‐to‐treat’ was performed for multivariable analysis.
Findings
Primary TB and alcohol end‐points between naltrexone and no‐naltrexone or BCI and no‐BCI groups did not differ significantly. TB treatment adherence and change in number of heavy drinking days also did not differ significantly among treatment arms. Among individuals with a prior quitting attempt (n = 111), naltrexone use was associated with an increased likelihood of favorable TB outcomes (92.3% versus 75.9%, P = 0.02).
Conclusions
In Tomsk Oblast, Russia, tuberculosis patients with severe alcohol use disorders who were not seeking alcohol treatment did not respond to naltrexone or behavioral counselling integrated into tuberculosis care; however, those patients with past attempts to quit drinking had improved tuberculosis outcomes.</description><subject>Addiction</subject><subject>Adult</subject><subject>Alcohol Abstinence</subject><subject>Alcohol Deterrents - therapeutic use</subject><subject>Alcohol interventions</subject><subject>alcohol use disorders</subject><subject>Alcoholism</subject><subject>Alcoholism - complications</subject><subject>Alcoholism - prevention & control</subject><subject>Behavior Therapy - methods</subject><subject>behavioral interventions</subject><subject>Clinical outcomes</subject><subject>clinical trial</subject><subject>Combined Modality Therapy</subject><subject>Compliance</subject><subject>Counseling</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Intervention</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Mycobacterium</subject><subject>Naltrexone - therapeutic use</subject><subject>Patient Compliance</subject><subject>Patients</subject><subject>Russia</subject><subject>Russian Federation</subject><subject>Treatment Outcome</subject><subject>Tuberculosis</subject><subject>Tuberculosis - complications</subject><subject>Tuberculosis - therapy</subject><issn>0965-2140</issn><issn>1360-0443</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk9v1DAQxSMEokvhwBdAkbhwIO04dhL7glS6_YOoQEVFHC3HHrfuJnGxnUK_Pe5uWQEnfPHY85unJ_sVxUsCeySvfWXMHqkJ44-KBaEtVMAYfVwsQLRNle9hp3gW4zUAdFywp8VOTZkACmxRrI6sRZ3cLU4YY-ltqQbtr_xQpoAqjTil0k0JQwaS81Ncny6DSmjuS18GPyc3YZnmHoOeBx9dLLUKmNvlhR_j6m35ZY7RqefFE6uGiC8e9t3i6_HRxeFpdfb55MPhwVmlG9byClkNvOe6p9Bpi8YoBYyIvjOW91Bb3RthrWlFS7Xm1FALbW14L9ByLlpDd4t3G92buR_R6Ow8qEHeBDeqcCe9cvLvzuSu5KW_lbQj0NQ8C7x5EAj--4wxydFFjcOgJvRzlIRR4A0V4n9Q0vGGQ91k9PU_6LWfw5RfQpKsRWsmWJ2pV3-a37r-_WUZ2N8AP9yAd9s-AXmfBZmzINdZkAfL5brIE9VmwsWEP7cTKqxk29Gukd8-ncjj0-X7jy2cy3P6C0bHuEc</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>Shin, Sonya</creator><creator>Livchits, Viktoria</creator><creator>Connery, Hilary Smith</creator><creator>Shields, Alan</creator><creator>Yanov, Sergei</creator><creator>Yanova, Galina</creator><creator>Fitzmaurice, Garrett M.</creator><creator>Nelson, Adrianne K.</creator><creator>Greenfield, Shelly F.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QG</scope><scope>7TK</scope><scope>8BJ</scope><scope>FQK</scope><scope>JBE</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>201308</creationdate><title>Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia</title><author>Shin, Sonya ; Livchits, Viktoria ; Connery, Hilary Smith ; Shields, Alan ; Yanov, Sergei ; Yanova, Galina ; Fitzmaurice, Garrett M. ; Nelson, Adrianne K. ; Greenfield, Shelly F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5468-e4208b8cb307cfeddaa0419b7df8b02fcbd9ffd6963cc83d3f062d8b9ef8896d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Addiction</topic><topic>Adult</topic><topic>Alcohol Abstinence</topic><topic>Alcohol Deterrents - therapeutic use</topic><topic>Alcohol interventions</topic><topic>alcohol use disorders</topic><topic>Alcoholism</topic><topic>Alcoholism - complications</topic><topic>Alcoholism - prevention & control</topic><topic>Behavior Therapy - methods</topic><topic>behavioral interventions</topic><topic>Clinical outcomes</topic><topic>clinical trial</topic><topic>Combined Modality Therapy</topic><topic>Compliance</topic><topic>Counseling</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Intervention</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Mycobacterium</topic><topic>Naltrexone - therapeutic use</topic><topic>Patient Compliance</topic><topic>Patients</topic><topic>Russia</topic><topic>Russian Federation</topic><topic>Treatment Outcome</topic><topic>Tuberculosis</topic><topic>Tuberculosis - complications</topic><topic>Tuberculosis - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Sonya</creatorcontrib><creatorcontrib>Livchits, Viktoria</creatorcontrib><creatorcontrib>Connery, Hilary Smith</creatorcontrib><creatorcontrib>Shields, Alan</creatorcontrib><creatorcontrib>Yanov, Sergei</creatorcontrib><creatorcontrib>Yanova, Galina</creatorcontrib><creatorcontrib>Fitzmaurice, Garrett M.</creatorcontrib><creatorcontrib>Nelson, Adrianne K.</creatorcontrib><creatorcontrib>Greenfield, Shelly F.</creatorcontrib><creatorcontrib>Tomsk Tuberculosis Alcohol Working Group</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Addiction (Abingdon, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Sonya</au><au>Livchits, Viktoria</au><au>Connery, Hilary Smith</au><au>Shields, Alan</au><au>Yanov, Sergei</au><au>Yanova, Galina</au><au>Fitzmaurice, Garrett M.</au><au>Nelson, Adrianne K.</au><au>Greenfield, Shelly F.</au><aucorp>Tomsk Tuberculosis Alcohol Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia</atitle><jtitle>Addiction (Abingdon, England)</jtitle><addtitle>Addiction</addtitle><date>2013-08</date><risdate>2013</risdate><volume>108</volume><issue>8</issue><spage>1387</spage><epage>1396</epage><pages>1387-1396</pages><issn>0965-2140</issn><eissn>1360-0443</eissn><coden>ADICE5</coden><abstract>Aims
To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia.
Design
Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enhancement therapy (BBCET), treatment as usual (TAU) and BCI.
Setting and participants
In the Tomsk Oblast, hospitalized TB patients diagnosed with alcohol use disorders (AUDs) by the DSM‐IV were referred at the start of TB treatment. Of the 196 participants, the mean age was 41 years and 82% were male. Severe TB (84.7% had cavitary disease) and smoking (92.9%) were common. The majority had a diagnosis of an AUD (63.0%); 27.6% reported nearly daily drinking and consumed a median of 16 standard drinks per day.
Measurements
Primary outcomes were ‘favorable’ TB outcome (cured, completed treatment) and change in mean number of abstinent days in the last month of study compared with baseline. Change in mean number of heavy drinking days, defined as four drinks per day and five drinks per day for women and men, respectively, and TB adherence, measured as percentage of doses taken as prescribed under direct observation, were secondary outcomes. Analysis based on ‘intention‐to‐treat’ was performed for multivariable analysis.
Findings
Primary TB and alcohol end‐points between naltrexone and no‐naltrexone or BCI and no‐BCI groups did not differ significantly. TB treatment adherence and change in number of heavy drinking days also did not differ significantly among treatment arms. Among individuals with a prior quitting attempt (n = 111), naltrexone use was associated with an increased likelihood of favorable TB outcomes (92.3% versus 75.9%, P = 0.02).
Conclusions
In Tomsk Oblast, Russia, tuberculosis patients with severe alcohol use disorders who were not seeking alcohol treatment did not respond to naltrexone or behavioral counselling integrated into tuberculosis care; however, those patients with past attempts to quit drinking had improved tuberculosis outcomes.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23490304</pmid><doi>10.1111/add.12148</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0965-2140 |
ispartof | Addiction (Abingdon, England), 2013-08, Vol.108 (8), p.1387-1396 |
issn | 0965-2140 1360-0443 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3710528 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Addiction Adult Alcohol Abstinence Alcohol Deterrents - therapeutic use Alcohol interventions alcohol use disorders Alcoholism Alcoholism - complications Alcoholism - prevention & control Behavior Therapy - methods behavioral interventions Clinical outcomes clinical trial Combined Modality Therapy Compliance Counseling Feasibility Studies Female Humans Intervention Male Medical treatment Mycobacterium Naltrexone - therapeutic use Patient Compliance Patients Russia Russian Federation Treatment Outcome Tuberculosis Tuberculosis - complications Tuberculosis - therapy |
title | Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T13%3A40%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20alcohol%20treatment%20interventions%20integrated%20into%20routine%20tuberculosis%20care%20in%20Tomsk,%20Russia&rft.jtitle=Addiction%20(Abingdon,%20England)&rft.au=Shin,%20Sonya&rft.aucorp=Tomsk%20Tuberculosis%20Alcohol%20Working%20Group&rft.date=2013-08&rft.volume=108&rft.issue=8&rft.spage=1387&rft.epage=1396&rft.pages=1387-1396&rft.issn=0965-2140&rft.eissn=1360-0443&rft.coden=ADICE5&rft_id=info:doi/10.1111/add.12148&rft_dat=%3Cproquest_pubme%3E1430853998%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1399324942&rft_id=info:pmid/23490304&rfr_iscdi=true |